Literature DB >> 17298762

Bile Acid malabsorption.

Henrik Westergaard1.   

Abstract

Patients with bile acid malabsorption typically present with chronic, watery diarrhea. Bile acids recirculate between the liver and small intestine in the enterohepatic circulation. They are reabsorbed in the distal small intestine, and normally only a small fraction of the bile acid pool is lost to the colon during each cycle. In patients with bile acid malabsorption, a larger amount of bile acids is spilled into the colon, where the acids stimulate electrolyte and water secretion, which results in loose to watery stools. The common causes of bile acid malabsorption are ileal resection and diseases of the terminal ileum (Crohn's disease and radiation enteritis), which result in a loss of bile acid transporters and, consequently, diminished reabsorption. Bile acid malabsorption also has been documented in a small group of patients with chronic, watery diarrhea who have no demonstrable ileal disease (idiopathic bile acid malabsorption). The amount of bile acid loss to the colon determines the clinical presentation. Patients with mild to moderate bile acid malabsorption present with watery diarrhea and generally respond very well to treatment (with abolishment of diarrhea) with bile acid binders such as cholestyramine. Patients with more severe bile acid malabsorption have both diarrhea and steatorrhea. Treatment with cholestyramine is of no benefit in this group of patients and may, in fact, worsen steatorrhea. These patients are best treated with a low-fat diet supplemented with medium-chain triglycerides.

Entities:  

Year:  2007        PMID: 17298762     DOI: 10.1007/s11938-007-0054-7

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  40 in total

1.  Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.

Authors:  A F Hofmann; J R Poley
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

2.  Cholestyramine treatment of diarrhea associated with ileal resection.

Authors:  A F Hofmann; J R Poley
Journal:  N Engl J Med       Date:  1969-08-21       Impact factor: 91.245

3.  Prognosis of adult-onset idiopathic bile acid malabsorption.

Authors:  P Rössel; H Sortsøe Jensen; P Qvist; A Arveschoug
Journal:  Scand J Gastroenterol       Date:  1999-06       Impact factor: 2.423

Review 4.  Intestinal bile acid transport: biology, physiology, and pathophysiology.

Authors:  B L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-04       Impact factor: 2.839

Review 5.  Colesevelam hydrochloride: a novel bile acid-binding resin.

Authors:  M A Aldridge; M K Ito
Journal:  Ann Pharmacother       Date:  2001 Jul-Aug       Impact factor: 3.154

6.  Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption.

Authors:  M Montagnani; M W Love; P Rössel; P A Dawson; P Qvist
Journal:  Scand J Gastroenterol       Date:  2001-10       Impact factor: 2.423

7.  Bowel habits and bile acid malabsorption in the months after cholecystectomy.

Authors:  Gerd H Sauter; Ahmed C Moussavian; Guenther Meyer; Heinrich O Steitz; Klaus G Parhofer; Dieter Jüngst
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

8.  Use of the SeHCAT test in the investigation of diarrhoea.

Authors:  G A Ford; J D Preece; I H Davies; S P Wilkinson
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

9.  Bile acid malabsorption in patients with chronic diarrhoea: clinical value of SeHCAT test.

Authors:  S Wildt; S Nørby Rasmussen; J Lysgård Madsen; J J Rumessen
Journal:  Scand J Gastroenterol       Date:  2003-08       Impact factor: 2.423

Review 10.  Bile acid malabsorption: mechanisms and treatment.

Authors:  S Eusufzai
Journal:  Dig Dis       Date:  1995 Sep-Oct       Impact factor: 2.404

View more
  13 in total

1.  Managing bile acid diarrhoea.

Authors:  Julian R F Walters; Sanjeev S Pattni
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 2.  Use and indications of cholestyramine and bile acid sequestrants.

Authors:  Franco Scaldaferri; Marco Pizzoferrato; Francesca Romana Ponziani; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  Intern Emerg Med       Date:  2011-07-08       Impact factor: 3.397

3.  Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.

Authors:  Laurent Vergnes; Jessica M Lee; Robert G Chin; Johan Auwerx; Karen Reue
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

Review 4.  Antioxidant properties of probiotics and their protective effects in the pathogenesis of radiation-induced enteritis and colitis.

Authors:  Basileios G Spyropoulos; Evangelos P Misiakos; Constantine Fotiadis; Christos N Stoidis
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

Review 5.  Bile Acid Diarrhea in Adults and Adolescents.

Authors:  Michael Camilleri; Samuel Nurko
Journal:  Neurogastroenterol Motil       Date:  2021-11-09       Impact factor: 3.598

6.  Enteroenteroanastomosis near adjacent ileocecal valve in infants.

Authors:  Wei-Wei Jiang; Xiao-Qun Xu; Qi-Ming Geng; Jie Zhang; Huan Chen; Xiao-Feng Lv; Chang-Gui Lu; Wei-Bing Tang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression.

Authors:  Olga Renner; Simone Harsch; Elke Schaeffeler; Matthias Schwab; Dietmar M Klass; Wolfgang Kratzer; Eduard F Stange
Journal:  Hum Genet       Date:  2009-01-30       Impact factor: 4.132

8.  Attenuated Accumulation of Novel Fluorine (19F)-Labeled Bile Acid Analogues in Gallbladders of Fibroblast Growth Factor-15 (FGF15)-Deficient Mice.

Authors:  Melissa Metry; Jessica Felton; Kunrong Cheng; Su Xu; Yong Ai; Fengtian Xue; Jean-Pierre Raufman; James E Polli
Journal:  Mol Pharm       Date:  2018-10-03       Impact factor: 4.939

9.  Analysis of Campylobacter jejuni infection in the gnotobiotic piglet and genome-wide identification of bacterial factors required for infection.

Authors:  Stefan P W de Vries; Aileen Linn; Kareen Macleod; Amanda MacCallum; Simon P Hardy; Gill Douce; Eleanor Watson; Mark P Dagleish; Hal Thompson; Andy Stevenson; David Kennedy; Abiyad Baig; Chris Coward; Duncan J Maskell; David G E Smith; Andrew J Grant; Paul Everest
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

10.  Measurement of serum 7α-hydroxy-4-cholesten-3-one as a marker of bile acid malabsorption in dogs with chronic diarrhoea: a pilot study.

Authors:  A C C Kent; G Cross; D R Taylor; R A Sherwood; P J Watson
Journal:  Vet Rec Open       Date:  2016-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.